Click here to know more about our subscription packages.
Want to commission a custom market research to suit your needs? We are here to help. Let us know.
As per NAVADHI Market Research, the global pharmaceutical industry will we worth USD 1.57 trillion by 2023.
Merck & Co., Inc. is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. The Company’s operations are principally managed on a products basis and include four operating segments, which are the Pharmaceutical, Animal Health, Healthcare Services and Alliances segments.
The Pharmaceutical segment includes human health pharmaceutical and vaccine products. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company sells these human health vaccines primarily to physicians, wholesalers, physician distributors and government entities.
Merck reported revenue of USD 42.294 billion for the FY 2018 which saw an increase of 5.41% compared to FY 2017. This revenue is expected to increase by 5.68% and reach USD 44.700 billion by FY 2019.
Merck & Co., Inc. registered highest revenue from oncology (Keytruda, Emend, Temodar, Alliance revenue – Lynparza and Alliance revenue - Lenvima) at USD 8.243 billion which accounted for 21.87% of its total pharmaceuticals sales in FY 2018.
Looking into 2019, Merck said it sees non-GAAP earnings of between $4.57 and $4.72 per share on worldwide sales of between $43.2 billion and $44.7 billion.
Spanning over 29 pages and 13 exhibits, “Merck & Co., Inc - Company Snapshot & SWOT Analysis” report provides value chain analysis, financial performance, business strategy and SWOT analysis for company.
Merck & Co., Inc.
Do you need more information about this report before making a purchase decision or wish to customize this report to suite your requirements?
If yes, then please use the form given below and we will get in touch with you immediately.
Kindly use your official email address and contact number to ensure speedy response.
View all our market research reports